Email Updates

You are here

Three Perspectives, Two Trials and One Big Goal

February 26, 2018

Px Pulse Logo

With more efficacy trials underway today than ever before in HIV prevention research, this episode of Px Pulse zooms in on two that have most recently launched: one of two trials testing a long-acting injectable antiretroviral called cabotegravir (HPTN 084), and the study of a "mosaic" vaccine developed by Janssen Pharmaceuticals (HVTN 705/HPX2008).

Veteran Malawian advocate Maureen Luba, Zimbabwe-based bioethicist Paul Ndebele, and leading scientist Dan Barouch each take up the subject of these trials and share their expertise on what they could mean for prevention nationally, regionally and globally.

Listen to the full podcast here (16:42)

Additional Resources
More Px Pulse

For more episodes of Px Pulse, click here.